Oral isotretinoin in the treatment of recalcitrant condylomata acuminata of the cervix: A randomised placebo controlled trial

Sexually Transmitted Infections

Volumn 80, Issue 3, 2004, Pages 216-218

  Georgala, S ^a,b   Katoulis, A C ^a   Georgala, C ^a   Bozi, E ^a   Mortakis, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ANDREAS SYGROS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ADULT; ARTICLE; CHEILITIS; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRY SKIN; EVALUATION; FEMALE; FOLLOW UP; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; UTERINE CERVIX DISEASE;

ADMINISTRATION, ORAL; ADULT; ANTI-INFECTIVE AGENTS; CONDYLOMATA ACUMINATA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOTRETINOIN; TREATMENT OUTCOME; UTERINE CERVICAL DISEASES;

EID: 2942605729     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2003.006841     Document Type: Article

References (12)

1. Garland SM. Human papillomavirus update with a particular focus on cervical disease. Pathology 2002;34:213-24.
2. Armstrong DKB, Maw RD, Dinsmore WW, et al. Combined therapy trial with interferon alpha-2a and ablative therapy in the treatment of anogenital warts. Genitourin Med 1996;72:103-7.
3. Zouboulis CC. Retinoids - which dermatological indications will benefit in the near future? Skin Pharmacol Appl Skin Physiol 2001;14:303-15.
4. Sporn MB, Roberts AB. Cervical dysplasia regression induced by all-transretinoic acid. J Natl Cancer Inst 1994;86:476-7.
5. Meyskens FL. Recent advances in the management of cancer with retinoids. Ann Oncol 1994;5(Suppl 9):529-32.
6. Olsen EA, Kelly FF, Vollmer RT, et al. Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata. J Am Acad Dermatol 1989;20:1023-30.
7. Tsambaos D, Georgiou S, Monastirli A, et al. Treatment of condylomata acuminata with oral isotretinoin. J Urol 1997;158:1810-2.
8. Cardamakis EK, Kotoulas IG, Dimopoulos DP, et al. Comparative study of systemic interferon alfa-2a with oral isotretinoin and oral isotretinoin alone in the treatment of recurrent condylomata acuminata. Arch Gynecol Obstet 1996;258:35-41.
9. Katz RA. Isotretinoin treatment of recalcitrant warts in an immunosuppressed man. Arch Dermatol 1986;122:19-20.
10. Lutzner MA, Blanchet-Bardon C, Puissant A. Oral aromatic retinoid (RO 10-9359) treatment of two patients suffering with the severe form of epidermodysplasia verruciformis. In: Orfanos CE, Braun-Falco O, Farber EM, eds. Retinoids: advances in basic research and therapy. New York: Springer-Verlag, 1981:407-10.
11. Stellmach V, Leask A, Fuchs E. Retinoid-mediated transcriptional regulation of keratin genes in human epidermal and squamous cell carcinoma cells. Proc Natl Acad Sci USA 1991;88:4582-6.
12. Oridate N, Lotan D, Follen Mitchell M, et al. Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemoprevention. J Cell Biochem 1995;(Suppl 23):80-6.